Arbutus Biopharma Corporation announced the company has appointed Lisa M. Caperelli to the newly created position of Vice President of Investor Relations, leading investor relations strategy and communications activities, reporting to David Hastings, Arbutus’ Chief Financial Officer. Ms. Caperelli has 20 years of demonstrated experience in leading the strategy and execution of comprehensive investor relations and corporate communications programs for various early- to commercial-stage publicly traded biotechnology companies. Most recently she held the position of Associate Vice President at Harmony Biosciences. Prior to Harmony, Lisa held roles of increasing responsibility in investor relations, corporate communications and patient advocacy with several biotech companies including Marinus Pharmaceuticals, Advaxis Inc., PolyMedix and Windtree Therapeutics Inc.